Study finds major methodological differences across seven direct-to-consumer stool tests, producing taxonomic profiles as variable as those between individuals — limiting clinical use.

Add Yahoo as a preferred source to see more of our stories on Google. What if you didn't have to get a colonoscopy every decade from ages 45 to 75? No, this isn't an excuse to skip screening for colon ...

A stool test is a diagnostic procedure that involves analyzing fecal matter, or poop, to check for signs of infection, inflammation, or disease. The specific analysis depends on a person’s symptoms ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

Medicare should cover a parasite poop test when medically necessary, usually when a person has symptoms of gastroenteritis or a history of exposure to a parasite. Laboratory technicians perform a ...

Researchers identified 218 gut bacterial subspecies linked to colorectal cancer. Subspecies-level analysis offers clearer insights than traditional species-level studies. New tools may enable ...

An investigational multitarget stool DNA test for screening colorectal cancer detects significantly more cancers than the currently available fecal immunochemical test (FIT), researchers report. But ...

A next-generation multitarget stool DNA test, including assessments of DNA molecular markers and hemoglobin level, was developed to improve the performance of colorectal cancer screening, primarily ...

Commercially available noninvasive screening tests for colorectal cancer - a fecal immunochemical test (FIT) and the multi-target stool DNAtest (mt-sDNA; or Cologuard ®) - are equally effective for ...